884 related articles for article (PubMed ID: 22146287)
1. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings.
Gore M; Sadosky A; Stacey BR; Tai KS; Leslie D
Spine (Phila Pa 1976); 2012 May; 37(11):E668-77. PubMed ID: 22146287
[TBL] [Abstract][Full Text] [Related]
2. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis.
Gore M; Tai KS; Sadosky A; Leslie D; Stacey BR
J Med Econ; 2011; 14(4):497-507. PubMed ID: 21682606
[TBL] [Abstract][Full Text] [Related]
3. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis.
Mehra M; Hill K; Nicholl D; Schadrack J
J Med Econ; 2012; 15(2):245-52. PubMed ID: 22136441
[TBL] [Abstract][Full Text] [Related]
4. Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings.
Gore M; Tai KS; Sadosky A; Leslie D; Stacey BR
Pain Pract; 2012 Sep; 12(7):550-60. PubMed ID: 22304678
[TBL] [Abstract][Full Text] [Related]
5. Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care.
Ivanova JI; Birnbaum HG; Schiller M; Kantor E; Johnstone BM; Swindle RW
Spine J; 2011 Jul; 11(7):622-32. PubMed ID: 21601533
[TBL] [Abstract][Full Text] [Related]
6. The burden associated with neuropathic pain in Western Europe.
Langley PC; Van Litsenburg C; Cappelleri JC; Carroll D
J Med Econ; 2013; 16(1):85-95. PubMed ID: 22970839
[TBL] [Abstract][Full Text] [Related]
7. Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research Database.
Hong J; Reed C; Novick D; Happich M
Spine (Phila Pa 1976); 2013 Jan; 38(1):75-82. PubMed ID: 23038621
[TBL] [Abstract][Full Text] [Related]
8. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
[TBL] [Abstract][Full Text] [Related]
9. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
J Med Econ; 2012; 15(1):19-31. PubMed ID: 21970699
[TBL] [Abstract][Full Text] [Related]
10. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
11. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
Asche CV; Joish VN; Camacho F; Drake CL
Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
[TBL] [Abstract][Full Text] [Related]
13. Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia.
Gore M; Sadosky A; Zlateva G; Clauw D
Am J Manag Care; 2010 May; 16(5 Suppl):S144-53. PubMed ID: 20586523
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin.
Gore M; Sadosky AB; Zlateva G; Clauw DJ
Pain Pract; 2009; 9(5):363-74. PubMed ID: 19500273
[TBL] [Abstract][Full Text] [Related]
15. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
Centorrino F; Mark TL; Talamo A; Oh K; Chang J
J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and characteristics of widespread pain in female primary health care patients with chronic low back pain.
Nordeman L; Gunnarsson R; Mannerkorpi K
Clin J Pain; 2012 Jan; 28(1):65-72. PubMed ID: 21677567
[TBL] [Abstract][Full Text] [Related]
18. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
19. Medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in France.
Depont F; Hunsche E; Abouelfath A; Diatta T; Addra I; Grelaud A; Lagnaoui R; Molimard M; Moore N
Fundam Clin Pharmacol; 2010 Feb; 24(1):101-8. PubMed ID: 19678853
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis.
Han C; Lofland JH; Zhao N; Schenkel B
J Drugs Dermatol; 2011 Aug; 10(8):843-50. PubMed ID: 21818505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]